MSH2 and neoplasm: MMR-deficient (MMR-d) status usually results from pathogenic alterations in the MMR core genes (MLH1, MSH2, MSH6, and PMS2), which are also associated with high microsatellite instability and high tumor mutational burden [1,2,3].